KRYS

175.64

2.87% 4.90

Dopo l'orario di chiusura: 175.64

Krystal Biotech Inc (KRYS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché KRYS Giù? Forum Previsione

Precedente Chiudi:

$170.74

Aprire:

$171.37

Volume 24 ore:

252.34K

Relative Volume:

1.17

Capitalizzazione di mercato:

$5.05B

Reddito:

$241.52M

Utile/perdita netta:

$52.37M

Rapporto P/E:

-119.48

EPS:

-1.47

Flusso di cassa netto:

$58.06M

1 W Prestazione:

-10.33%

1M Prestazione:

-1.98%

6M Prestazione:

+7.03%

1 anno Prestazione:

+68.63%

Intervallo 1D:

$168.88

$176.44

Intervallo di 1 settimana:

$168.88

$199.41

Portata 52W:

$99.00

$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Nome

Krystal Biotech Inc

Settore

Healthcare (1196)

Industria

Biotechnology (683)

Telefono

(412) 586-5830

Indirizzo

2100 WHARTON STREET, PITTSBURGH, PA

Dipendente

229

Cinguettio

@KrystalBiotech

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

KRYS's Discussions on Twitter

Confronta KRYS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KRYS	175.64	5.05B	241.52M	52.37M	58.06M	-1.47
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-20	Iniziato	Goldman	Buy
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-10-12	Iniziato	Citigroup	Buy
2023-09-07	Iniziato	Berenberg	Buy
2023-04-18	Iniziato	Stifel	Buy
2023-02-28	Aggiornamento	Goldman	Neutral → Buy
2022-08-25	Downgrade	Goldman	Buy → Neutral
2022-01-18	Iniziato	BofA Securities	Buy
2021-07-20	Aggiornamento	Goldman	Neutral → Buy
2020-09-18	Iniziato	B. Riley FBR	Buy
2020-06-04	Iniziato	Evercore ISI	Outperform
2019-09-24	Iniziato	Goldman	Neutral
2019-08-06	Reiterato	H.C. Wainwright	Buy
2019-06-24	Reiterato	Chardan Capital Markets	Buy
2019-06-24	Reiterato	H.C. Wainwright	Buy
2019-05-30	Iniziato	Guggenheim	Buy
2018-09-11	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Krystal Biotech Inc Borsa (KRYS) Ultime notizie

Nov 15, 2024

Redmile Group, LLC Adjusts Stake in Krystal Biotech Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 12, 2024

Nov 11, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by TimesSquare Capital Management LLC - MarketBeat

Nov 11, 2024

Nov 09, 2024

Janney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Chardan Capital Predicts Lower Earnings for Krystal Biotech - MarketBeat

Nov 08, 2024

Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Simply Wall St

Nov 07, 2024

Q2 EPS Estimates for Krystal Biotech Raised by William Blair - MarketBeat

Nov 07, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

Nov 07, 2024

HC Wainwright Predicts Reduced Earnings for Krystal Biotech - MarketBeat

Nov 07, 2024

Nov 06, 2024

HC Wainwright Forecasts Higher Earnings for Krystal Biotech - MarketBeat

Nov 06, 2024

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - StockTitan

Nov 06, 2024

Krystal Biotech FY2024 EPS Forecast Raised by William Blair - MarketBeat

Nov 06, 2024

Nov 05, 2024

Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction - MSN

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at Citigroup - MarketBeat

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 05, 2024

Krystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat

Nov 05, 2024

Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 05, 2024

Krystal stock gains modest boost from Citi, but compliance risks linger - Investing.com Canada

Nov 05, 2024